Ir.quidelortho.com is a subdomain of Quidelortho.com, which was created on 2022-03-24,making it 2 years ago.
Discover ir.quidelortho.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
HomePage size: 112.892 KB |
Page Load Time: 0.178006 Seconds |
Website IP Address: 162.159.129.11 |
Synopsys, Inc. | Investor Relations & Investor Resources investor.synopsys.com |
Masonite International Corp. - Investor Relations - Investor Relations investor.masonite.com |
Block, Inc. (SQ) Investor Relations - Investor Relations investors.block.xyz |
Gen Investor Relations - Investor Relations investor.gendigital.com |
MindChamps PreSchool Limited - Investor Relations: Investor Relations investor.mindchamps.org |
USD Partners Investor Center - Investor Center investor.usdpartners.com |
Home - Ayala Land Investor Relations : Ayala Land Investor Relations ir.ayalaland.com.ph |
Equitable Bank Investor Relations - Investor Relations eqbank.investorroom.com |
English | QuidelOrtho orthoconnect.orthoclinical.com |
Ameriprise Financial Investor Relations | Investor Relations ir.ameriprise.com |
Matt McCall's Early Stage Investor Account : Matt McCall's Early Stage Investor nexgenprofitmultiplier.investorplace.com |
Meridian Bank Investor Relations - Meridian Bank Investor Relations investor.meridianbanker.com |
Armstrong World Industries Investor Relations | Armstrong Flooring Investor Relations ir.armstrong.com |
QuidelOrtho Corporation - Investor Relations https://ir.quidelortho.com/home/default.aspx |
Corporate Profile https://ir.quidelortho.com/corporate-profile/default.aspx |
QuidelOrtho Corporation - News Releases https://ir.quidelortho.com/news/default.aspx |
QuidelOrtho Corporation - Governance https://ir.quidelortho.com/governance/ |
QuidelOrtho Corporation - Resources https://ir.quidelortho.com/resources/default.aspx |
QuidelOrtho Corporation - Stock Information https://ir.quidelortho.com/stock-information/default.aspx |
QuidelOrtho Corporation - Cautionary Information https://ir.quidelortho.com/advisory-information/default.aspx |
ESG https://ir.quidelortho.com/ESG/default.aspx |
QuidelOrtho Corporation - QuidelOrtho Reports Fourth Quarter and Full ... https://ir.quidelortho.com/news/news-release-details/2023/QuidelOrtho-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-Results/default.aspx |
QuidelOrtho Corporation - QuidelOrtho Reports Preliminary Revenue ... https://ir.quidelortho.com/news/news-release-details/2023/QuidelOrtho-Reports-Preliminary-Revenue-Results-for-the-First-Quarter-2023/default.aspx |
QuidelOrtho Reports Third Quarter 2023 Financial Results https://ir.quidelortho.com/news/news-release-details/2023/QuidelOrtho-Reports-Third-Quarter-2023-Financial-Results/ |
QuidelOrtho Corporation - Quidel Corporation Signs Definitive Agreement ... https://ir.quidelortho.com/news/news-release-details/2021/Quidel-Corporation-Signs-Definitive-Agreement-to-Acquire-Ortho-Clinical-Diagnostics/default. |
QuidelOrtho Reports Second Quarter 2022 Financial Results https://ir.quidelortho.com/news/news-release-details/2022/QuidelOrtho-Reports-Second-Quarter-2022-Financial-Results/ |
QuidelOrtho Corporation - Stock Information https://ir.quidelortho.com/stock-information/ |
QuidelOrtho Reports Second Quarter 2023 Financial Results https://ir.quidelortho.com/news/news-release-details/2023/QuidelOrtho-Reports-Second-Quarter-2023-Financial-Results/default.aspx |
Date: Wed, 15 May 2024 11:54:45 GMT |
Content-Type: text/html; charset=utf-8 |
Content-Length: 93625 |
Connection: keep-alive |
CF-Ray: 8842ef649ae10cef-LAX |
CF-Cache-Status: REVALIDATED |
Accept-Ranges: bytes |
Cache-Control: public, max-age=10, stale-if-error=86400, stale-while-revalidate=86400 |
ETag: 49718741118bd82c7c1d8b5563a7f126 |
Strict-Transport-Security: max-age=31536000; includeSubDomains |
Vary: Accept-Encoding |
X-Content-Type-Options: nosniff |
X-XSS-Protection: 1; mode=block |
Server: |
content="text/html; charset=utf-8" http-equiv="Content-type"/ |
content="RevealTrans(Duration=0,Transition=0)" http-equiv="Page-Enter"/ |
content="IE=edge,chrome=1" http-equiv="X-UA-Compatible"/ |
content="width=device-width, initial-scale=1" |
Relations Corporate Site Home Corporate Profile News Releases Events & Presentations Events Calendar Presentations Archived Events & Presentation Stock Information Stock Quote Stock Chart Historical Stock Quote Investment Calculator Analyst Coverage Fundamentals Form 8937 Financials Quarterly Results Annual Reports SEC Filings Governance Governance Documents Leadership Team Board of Directors Committee Composition Board Diversity Matrix Animal Testing Policy Resources Investor FAQs Information Request Form Investor Email Alerts Cautionary Information ESG ESG Mission Statement Responsible Advertising and Sales Statement Diversity, Equity, and Inclusion Statement Workforce and Labor Rights Policy Supplier Code of Conduct Environmental and Safety Policy Quality Management System Certification Quidel Waste Metrics Quidel Incident Rates Quidel SASB Table Quidel Commitment to Cybersecurity Conflict Minerals Policy Ortho 2022 Sustainability Report Investor Relations Corporate Profile Home Corporate Profile News Releases Events & Presentations Events Calendar Presentations Archived Events & Presentation Stock Information Stock Quote Stock Chart Historical Stock Quote Investment Calculator Analyst Coverage Fundamentals Form 8937 Financials Quarterly Results Annual Reports SEC Filings Governance Governance Documents Leadership Team Board of Directors Committee Composition Board Diversity Matrix Animal Testing Policy Resources Investor FAQs Information Request Form Investor Email Alerts Cautionary Information ESG ESG Mission Statement Responsible Advertising and Sales Statement Diversity, Equity, and Inclusion Statement Workforce and Labor Rights Policy Supplier Code of Conduct Environmental and Safety Policy Quality Management System Certification Quidel Waste Metrics Quidel Incident Rates Quidel SASB Table Quidel Commitment to Cybersecurity Conflict Minerals Policy Ortho 2022 Sustainability Report Corporate Site Corporate Profile QuidelOrtho Corporation (Nasdaq: QDEL) unites the power of Quidel Corporation and Ortho Clinical Diagnostics behind a shared mission of developing and manufacturing innovative technologies that raise the performance of diagnostic testing and create better patient outcomes across the entire healthcare continuum. Ranked among the world’s largest in vitro diagnostics (IVD) providers, QuidelOrtho is building on more than 120 years of collective experience and innovation. We combine industry-leading expertise in immunoassay and molecular testing with a global footprint in point-of-care settings, clinical labs and transfusion medicine to advance critical diagnostic solutions at scale. Read MoreRecent News View All News Recent and Upcoming Events View All Events Investor Presentation Quarterly Results View All Quarters Archived financial results Select a year: Analyst Coverage Firm Analyst Phone Barclays Capital Jack Meehan 212-526-3909Canaccord Genuity Mark Massaro 617-371-3769Citi Patrick Donnelly 212-816-0701 Craig-Hallum Capital Group Alex Nowak, CFA 612-334-6347 J.P. Morgan Casey Woodring 212-622-9074 Nephron Research Jack Meehan, CFA 646-214-0299 Piper Sandler Rachel Vatnsdal Steven Mah 612 303-6441 212 284-9341Raymond James Andrew Cooper 727-567-2295 RBC Capital Markets Conor McNamara, CFA 619-782-5265 UBS Elizabeth Garcia 212-713-2697 William Blair Andrew Brackmann, CFA 312-364-8776 As of December 2022, QuidelOrtho Corporation is aware that it is followed by the analysts listed above; however, it is possible that the list above is not complete. Please note that any opinions, estimates or forecasts regarding QuidelOrtho Corporation’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of QuidelOrtho Corporation or its management. QuidelOrtho Corporation does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations. Interactive Analyst center Income Statements (in millions, except per share amounts) View more details Supplemental Notice of Privacy Rights to Residents of CaliforniaSupplemental Notice of Privacy Rights to Residents of California Supplemental Notice of Privacy Rights for residents of European Economic AreaSupplemental Notice of Privacy Rights for residents of European Economic Area Website Privacy NoticeWebsite Privacy Notice Website Terms of UseWebsite Terms of Use Investor Alerts To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time. At QuidelOrtho Corporation, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance. By providing your email address below, you are providing consent to QuidelOrtho Corporation to send you the requested Investor Email Alert updates. * Required Email Address * Mailing Lists * News Events SEC Filings Annual Reports Financial Report Email Alert Sign Up Confirmation Investor Contact Juliet Cunningham QuidelOrtho Vice President, Investor Relations Juliet.cunningham@quidelortho.com Jackie Marcus Nick Teves Alpha IR Vice President, Investor Relations858-646-8023 ruben.argueta@quidel.comIR@QuidelOrtho.com Transfer Agent AMERICAN STOCK TRANSFER & TRUST COMPANY LLC. (800) 937-5449 or (718)921-8124 help@astfinancial.com https://www.astfinancial.com/Website: www.computershare.com Telephone inquiries: 1-800-736-3001, option 1 (U.S.) 1-781-575-3100, option 1 (non-U.S.) E-mail inquiries: web.queries@computershare.com QuidelOrtho Corporation. All rights reserved.Copyright © 2022 QuidelOrtho Corporation. All rights reserved. Powered By Q4 Inc. 5.122.0.3 (opens in...
Domain Name: QUIDELORTHO.COM Registry Domain ID: 2683975913_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2024-03-25T12:15:42Z Creation Date: 2022-03-24T15:55:53Z Registry Expiry Date: 2026-03-24T15:55:53Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS1-01.AZURE-DNS.COM Name Server: NS2-01.AZURE-DNS.NET Name Server: NS3-01.AZURE-DNS.ORG Name Server: NS4-01.AZURE-DNS.INFO DNSSEC: unsigned >>> Last update of whois database: 2024-05-18T02:51:52Z <<<